Hearing loss risks after childhood cancer treatment
Part of Cancer, Ear, nose & throat, Injuries & trauma clinical trials.
This study looks at why some childhood cancer survivors develop hearing loss later in life. By examining past treatments, researchers hope to identify risk factors and improve long-term follow-up care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You were treated for a brain tumor, solid tumor, lymphoma, or leukemia when you were under 25.
- You have been cancer-free for at least 5 years.
- You are part of a specific long-term survivor study or have follow-up care at Curie Institute or Gustave Roussy.
- You have health insurance (Social security coverage).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at hearing problems caused by cancer treatments that can damage the ears or nervous system. It aims to better understand and diagnose these side effects to help patients.
This study looks at how children's bodies respond to radiation therapy for certain cancers. By analyzing blood samples, researchers hope to learn why some children experience more side effects, which could help personalize future treatments.
This study compares how patients’ quality of life changes when people who have hearing loss from platinum chemotherapy use a hearing aid versus not using one. It may help understand whether hearing aids improve daily life during treatment.
This study looks at how cisplatin chemotherapy affects hearing and balance in people with head and neck cancer. It compares those getting cisplatin-based treatment to those getting only radiation. The goal is to better understand and potentially reduce these side effects.
This study looks at how tinnitus (ringing in the ears) and hearing problems may develop after radiotherapy alone or with certain chemotherapy for high-risk head and neck cancer. The goal is to better understand who is more likely to experience these side effects.
This study follows children with solid cancers who get certain chemotherapy or head/neck radiation, to better catch early hearing loss and plan hearing support. It’s mainly observational, meaning it tracks outcomes and helps develop future follow-up and hearing rehabilitation programs.
Hear when a new Ototoxicity, Drug-Induced trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.